172 related articles for article (PubMed ID: 1285276)
21. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
23. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
24. Detection of gastrin and its messenger RNA in Zollinger-Ellison tumors by non-radioactive in situ hybridization and immunocytochemistry.
Larsson LI; Hougaard DM
Histochemistry; 1992; 97(2):105-10. PubMed ID: 1559841
[TBL] [Abstract][Full Text] [Related]
25. Location, incidence, and malignant potential of duodenal gastrinomas.
Thom AK; Norton JA; Axiotis CA; Jensen RT
Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
27. Concurrent gastrinoma and somatostatinoma in a 10-year-old Portuguese water dog.
Hoenerhoff M; Kiupel M
J Comp Pathol; 2004 May; 130(4):313-8. PubMed ID: 15053935
[TBL] [Abstract][Full Text] [Related]
28. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization.
Lloyd RV; Fields K; Jin L; Horvath E; Kovacs K
Am J Pathol; 1990 Aug; 137(2):479-88. PubMed ID: 2167013
[TBL] [Abstract][Full Text] [Related]
29. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
[TBL] [Abstract][Full Text] [Related]
30. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas.
Fendrich V; Langer P; Waldmann J; Bartsch DK; Rothmund M
Br J Surg; 2007 Nov; 94(11):1331-41. PubMed ID: 17939142
[TBL] [Abstract][Full Text] [Related]
31. Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion.
Pelte MF; Schwaller J; Cerrato C; Meier CA
Breast J; 2004; 10(4):350-4. PubMed ID: 15239795
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
34. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
Goebel SU; Iwamoto M; Raffeld M; Gibril F; Hou W; Serrano J; Jensen RT
Cancer Res; 2002 Jul; 62(13):3702-10. PubMed ID: 12097278
[TBL] [Abstract][Full Text] [Related]
35. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.
Anlauf M; Perren A; Meyer CL; Schmid S; Saremaslani P; Kruse ML; Weihe E; Komminoth P; Heitz PU; Klöppel G
Gastroenterology; 2005 May; 128(5):1187-98. PubMed ID: 15887103
[TBL] [Abstract][Full Text] [Related]
36. Duodenal microgastrinomas associated with Zollinger-Ellison syndrome.
Schröder W; Hölscher AH; Beckurts T; Richter TH; Höfler H; Siewert JR
Hepatogastroenterology; 1996; 43(12):1465-9. PubMed ID: 8975949
[TBL] [Abstract][Full Text] [Related]
37. Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor.
Norton JA
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):699-704. PubMed ID: 16253894
[TBL] [Abstract][Full Text] [Related]
38. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
39. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
40. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]